Editorial: Bioresorbable stents: The next revolution

Circulation

Volumn 122, Issue 22, 2010, Pages 2236-2238

  Bittl, John A ^a  

^a Munroe Regional Med Center   (United States)

Author keywords

biodegradable polymers; drug eluting stent; Editorials; percutaneous coronary intervention; stent optimization; stent thrombosis

Indexed keywords

BARE METAL STENT; DRUG ELUTING STENT; EDITORIAL; HEART INFARCTION; PRIORITY JOURNAL; STENT; STENT THROMBOSIS; ANIMAL; BIODEGRADABLE IMPLANT; CORONARY ARTERY DISEASE; HUMAN; NOTE;

LACTIC ACID; METAL; POLYLACTIC ACID; POLYMER; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; ANIMALS; CORONARY DISEASE; HUMANS; LACTIC ACID; METALS; POLYMERS; STENTS; TISSUE SCAFFOLDS;

EID: 78650107203     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.988469     Document Type: Editorial

References (18)

1. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angio-plasty: a serial intravascular ultrasound study. Circulation. 1996;94: 35-43. (Pubitemid 126426397)
2. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56:S1-S42.
3. Daemen J, Wenaseser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-678. (Pubitemid 46281313)
4. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118:1138-1145.
5. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation. 2000; 102:399-404. (Pubitemid 30490677)
6. Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol. 2010;56:S43-S78.
7. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122:2301-2312.
8. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MWI, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. (Pubitemid 351384734)
9. Tanimoto S, Serruys PW, Thuesen L, Dukek D, de Bruyne B, Chevalier B, Ormiston JA. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv. 2007;70:515-523. (Pubitemid 47597022)
10. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Hébert KM, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
11. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, COURAGE Trial Research Group. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677-687.
12. Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, Fajadet J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J-J, Disco CMC, Morel MA, Benestent Group. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol. 2001;37: 1598-1603.
13. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J. 2004;147:815-822. (Pubitemid 38880987)
14. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373:911-918.
15. Kirtane AJ, Gupta H, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie BR, Hannan EL, Harjai K, Jensen LO, Park SJ, Perry R, Racz MJ, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: meta-analysis of randomized trials and observational studies. Circulation. 2009;119: 3198-3206.
16. Consumer Reports. 10 overused tests and treatments. http://www. consumerreports.org/health/doctors-hospitals/medical-ripoffs/ 10-overused-tests-and-treatments/medical-ripoffs-ten-over-1.htm. Accessed October 4, 2010.
17. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ; SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010; 362:1663-1674.
18. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M-C, di Mario C, Davies S, van Geuns R-J, Eerdmans P, van Es G-E, Meier B, Jüni P. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revasculari-sation (LEADERS): a randomised non-inferiority trial. Lancet. 2008;372:1163-1173.